Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2012
04/19/2012WO2011149310A3 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
04/19/2012WO2011143194A3 System and method for processing a biological sample
04/19/2012WO2011143124A3 Endoribonuclease compositions and methods of use thereof
04/19/2012WO2011139629A3 Light targeting molecules and uses thereof
04/19/2012WO2011137414A3 Defense peptides againts fungal infection and method of their use
04/19/2012WO2011136602A3 Method for selecting antibody-producing cell line, and kit thereof
04/19/2012WO2011136506A3 Method for producing recombinant complex antigens using nanoparticles of human rotavirus
04/19/2012WO2011133935A3 Methods and kits for risk assessment of barrett's neoplastic progression
04/19/2012WO2011133704A3 Modified polypeptides and proteins and uses thereof
04/19/2012WO2011132872A9 Information providing method for diagnosis of tuberculosis, and tuberculosis diagnostic kit for same
04/19/2012WO2011130725A3 Production of organic acids from xylose rich hydrolysate by bacterial fermentation
04/19/2012WO2011130618A3 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
04/19/2012WO2011127393A3 Variants of ancestral uricases and uses thereof
04/19/2012WO2011127337A3 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
04/19/2012WO2011126864A3 Cancer treatment with recombinant vector
04/19/2012WO2011126856A3 Herpes simplex virus mutant icp0
04/19/2012WO2011123826A3 Prevention and treatment of cast nephropathy
04/19/2012WO2011123745A3 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
04/19/2012WO2011119920A9 Cmv glycoproteins and recombinant vectors
04/19/2012WO2011116184A3 Methods and compositions for targeted mutagenesis in bacteria
04/19/2012WO2011116120A3 Method and apparatus for addressable flow cells in single molecule sequencing
04/19/2012WO2011116094A3 Live attenuated chimeric porcine circovirus vaccine
04/19/2012WO2011115810A3 Isoform-specific rnai based on codon redundancy/degeneracy
04/19/2012WO2011113030A3 Human cancer micro-rna expression profiles predictive of chemo-response
04/19/2012WO2011109705A3 Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification
04/19/2012WO2011106356A8 Diagnositic methods of tumor suspceptibility with single nucleotide polymorphisms inside microrna target sites
04/19/2012WO2011103300A3 Improving activity of fe-s cluster requiring proteins
04/19/2012WO2011098285A3 Dermatological, pharmaceutical composition suitable for oligonucleotides
04/19/2012WO2011042901A8 Brucella phage polynucleotides and uses thereof
04/19/2012US20120096599 Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
04/19/2012US20120096597 Polypeptides having Beta-glucosidase Activity and Polynucleotides Encoding Same
04/19/2012US20120096596 Regulators involved in mushroom formation
04/19/2012US20120096595 Virus induced gene silencing (vigs) for functional analysis of genes in cotton
04/19/2012US20120096594 Soybean Transformation Method
04/19/2012US20120096593 Plants Having Enhanced Yield-Related Traits And/Or Enhanced Abiotic Stress Tolerance And A Method For Making The Same
04/19/2012US20120096592 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
04/19/2012US20120096591 Identification and Validation of Novel Targets for Agrochemicals
04/19/2012US20120096590 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
04/19/2012US20120096588 Dgat genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
04/19/2012US20120096587 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
04/19/2012US20120096586 Markerless transformation
04/19/2012US20120096585 System for expression of genes in plants
04/19/2012US20120096584 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
04/19/2012US20120096583 Methods and compositions for enhanced gene expression through intron free energy reduction
04/19/2012US20120096581 Methods of producing polyketide synthase mutants and compositions and uses thereof
04/19/2012US20120096580 Zantedeschia Variety 110224-64275
04/19/2012US20120096579 Zantedeschia Variety 110066-21104
04/19/2012US20120096575 Tomato hybrid ps02420487 and parent lines thereof
04/19/2012US20120096574 Tomato hybrid ps01819578
04/19/2012US20120096573 Process for Generating Transgenic Animals Using Recombinant Lentiviruses
04/19/2012US20120096571 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120096568 Transgenic lsd1 animal model for cancer
04/19/2012US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same
04/19/2012US20120095193 Polypeptides and method of treatment
04/19/2012US20120095191 Lh-type bispecific antibody
04/19/2012US20120095188 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
04/19/2012US20120095086 Protein tyrosine phosphatase mutations in cancers
04/19/2012US20120095084 Modulation of serotonin neurons involving the pet-1 transcriptional control region
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095080 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
04/19/2012US20120095076 Compositions and methods for inhibiting expression of huntingtin gene
04/19/2012US20120094937 Mammalian cell surface antigens; related reagents
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094908 Truncated activin type ii receptor and methods of use
04/19/2012US20120094906 Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094873 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
04/19/2012US20120094870 Library of a Collection of Cells
04/19/2012US20120094386 Engineering salt tolerance in photosynthetic microorganisms
04/19/2012US20120094385 Gene positioning system for plastidic transformation and products thereof
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
04/19/2012US20120094377 Modified Fluorescent Proteins and Methods for Using Same
04/19/2012US20120094375 Enhanced engineered native promoters and uses thereof
04/19/2012US20120094374 Micrornas and uses thereof
04/19/2012US20120094352 Method for cell identification and cell sorting
04/19/2012US20120094345 Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors
04/19/2012US20120094343 Gene Knockout Mesophilic and Thermophilic Organisms, and Methods of Use Thereof
04/19/2012US20120094335 Archael laccases and multicopper oxidases (mcos) and their uses thereof
04/19/2012US20120094332 Dna polymerases and mutants thereof
04/19/2012US20120094329 Increasing protein production by increasing abc50 expression or activity
04/19/2012US20120094320 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same
04/19/2012US20120094297 Method For Producing Protein
04/19/2012US20120094294 Bms1 protein expression system
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120093919 E2f as a target of hormone refractory prostate cancer
04/19/2012US20120093916 Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of SIRNA
04/19/2012US20120093913 Inhibition of SYK kinase expression
04/19/2012US20120093871 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093850 Compositions for immunising against staphylococcus aureus
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093846 Protein for the immunocastration for mammals
04/19/2012US20120093845 Neil3 peptides and vaccines including the same
04/19/2012US20120093843 Tem8 peptides and vaccines comprising the same
04/19/2012US20120093842 Chimeric receptor genes and cells transformed therewith